News Flash >

Women's Health

 

Research Suggests Genetic Risk for Virus-Related Malignancy in Indian Women (Cervical Cancer-February 11, 2003)


"The objective of the present study was to determine the codon 72 genotypic frequencies of p53 in Indian women and to analyze the association of this polymorphism with human papillomavirus (HPV) related cervical cancer (CaCx). We used tissues derived from 55 women diagnosed with squamous cell carcinoma of the cervix (of whom 46 were HPV types 16/18 positive) and cervical scrapes derived from 201 cytologically normal women (of whom 84 were HPV types 16/18 positive) as controls. The DNA isolated from these samples was genotyped for p53 polymorphism by polymerase chain reaction and restriction fragment length polymorphism method," researchers in India reported.

"The genotypic frequency of homozygous arginine among women with CaCx was 27% and this did not differ with the controls. But, proline homozygosity of 33% in the malignant samples was significantly higher than controls (OR=2.23; 95% CI: 1.14-4.35; P=0.02). The associated risk of this genotype towards CaCx was more prominent (OR=2.67; 95% CI: 1.16-6.15; P=0.02) when analysis was restricted to HPV 16/18 positive women," stated P. Bhattacharya and colleagues, Indian Statistics Institute, Biochemistry Unit.

"Thus, proline homozygosity at codon 72 of p53 and not arginine homozygosity could be a risk factor for development of CaCx associated with high risk HPV among Indian women," concluded the researchers.

Bhattacharya and colleagues published their study in Cancer Letters (Proline homozygosity in codon 72 of p53: a risk genotype for human papillomavirus related cervical cancer in Indian women. Cancer Lett, 2002;188(1-2):207-211).

The contact person for this report is S. Sengupta, Indian Statistics Institute, Biochemistry Unit, 203 BT Rd., Kolkata 700108, India.

The information in this article comes under the major subject areas of Cervical Cancer, Genomics and Genetics, Gynecology, Infectious Disease, Oncology, Squamous Cancer, Virology and Women's Health. This article was prepared by Virus Weekly editors from staff and other reports.

 ©Copyright 2003, Virus Week via NewsRx.com & NewsRx.net

This story has been adapted from a news release issued by NewsRx.com & NewsRx.net